IP Library Granted Patent US 8,853,431
Granted Patent B2
US 8,853,431 · App. 12/147,828 · Granted Oct 7, 2014

Process for the preparation of 17-(3-hydroxypropyl)-17-hydroxysteroids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,853,431
App. No.
12/147,828
Granted
Oct 7, 2014
Kind
B2
Abstract

The present invention relates to a process for the preparation of 17α-(3-hydroxypropyl)-17β-hydroxysteroids of the formula I starting from 17-ketosteroids of the formula III via the intermediates of the formula V wherein the radicals R 3 , R 5 , R 6 , R 7 , R 10 , R 13 , R 15 , R 16 , R 40 , R 41 and R 42 have the meaning indicated in the description.

Claims (70)

1. A compound of formula V

wherein

R 3 is hydrogen or

R 30 , R 31 , R 32 are, independently of one another, hydrogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy;

R 5 is hydrogen, or hydroxyl or together with R 6 can be a double bond;

R 6 is hydrogen, or together with R 5 or R 7 is a double bond; or together with R 7 is an α or β-CH 2 group;

R 7 is hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -thioacyl; or together with R 6 is a double bond or an α or β-CH 2 group;

R 10 is hydrogen, methyl or ethyl;

R 13 is methyl, or ethyl;

R 15 is hydrogen, or C 1 -C 4 -alkyl, or together with R 16 is a —CH 2 group or a double bond;

R 16 is hydrogen or together with R 15 is a —CH 2 group or a double bond, and

R 40 , R 41 , R 42 independently of one another is hydrogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy.

2. A compound according to claim 1 , which is a compound of formula Va

3. A compound according to claim 1 , which is a compound of formula Vb

4. A compound according to claim 1 , which is 6β,7β;15β,16β-dimethylene-17α-(3-benzyloxypropynyl)androstane-3β,5β,17β-triol.

5. 1 A process in which a reaction of a compound of formula V according to claim 1 leads to the preparation of a 17α-(3-hydroxypropyl)-17β-hydroxysteroid of formula I

comprising

a) reacting a 17-ketosteroid of formula III

wherein

R 3 is hydrogen or the group

R 30 , R 31 , R 32 are, independently of one another, hydrogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy;

R 5 is hydrogen, or hydroxyl or together with R 6 is a double bond;

R 6 is hydrogen, or together with R 5 or R 7 is a double bond; or together with R 7 is an α or β-CH 2 group;

R 7 is hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -thioacyl; or together with R 6 is a double bond or an α or β-CH 2 group;

R 10 is hydrogen, methyl or ethyl;

R 13 is methyl, or ethyl;

R 15 is hydrogen, or C 1 -C 4 -alkyl, or together with R 16 is a —CH 2 group or a double bond; and

R 16 is hydrogen or together with R 15 is a —CH 2 group or a double bond,

in the presence of a base,

with a prop-1-yn-3-ol ether of formula IV

wherein

R 40 , R 41 , R 42 are, independently of one another, hydrogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy,

to give a compound of formula V

b) completely catalytic hydrogenating the alkyne function of the compound of formula V,

and

c) removing the benzylic protective group.

6. A process according to claim 5 , wherein in the compound of formula III

R 5 is hydrogen or hydroxyl;

R 6 is hydrogen or together with R 7 is an α or β-CH 2 group;

R 7 is hydrogen or an α or β-CH 2 group;

R 10 is hydrogen, methyl or ethyl;

R 13 is methyl, or ethyl;

R 15 is hydrogen, or C 1 -C 4 -alkyl, or together with R 16 is a —CH 2 group; and

R 16 is hydrogen or together with R 15 is a —CH 2 group.

7. A process according to claim 5 , wherein the compound of formula I is a compound of formula Ia

wherein the compound of formula III is a compound of formula IIIa

and wherein the compound of formula V is a compound of formula Va

8. A process according to claim 5 , wherein the prop-1-yn-3-ol ether is a compound of formula IVa

9. A process according to claim 5 , wherein the compound of formula I is a compound of formula Ia

wherein the compound of formula III is a compound of formula IIIa

wherein the compound of formula IV is a compound of formula IVa

and wherein the compound of formula V is a compound of formula Vb

10. A process for preparing a compound of formula V

comprising

reacting a 17-ketosteroid of formula III

wherein

R 3 is hydrogen or the group

R 30 , R 31 , R 32 are, independently of one another, hydrogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy;

R 5 is hydrogen, or hydroxyl or together with R 6 is a double bond;

R 6 is hydrogen, or together with R 5 or R 7 is a double bond; or together with R 7 is an α or β-CH 2 group;

R 7 is hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -thioacyl; or together with R 6 is a double bond or an α or β-CH 2 group;

R 10 is hydrogen, methyl or ethyl;

R 13 is methyl, or ethyl;

R 15 is hydrogen, or C 1 -C 4 -alkyl, or together with R 16 is a —CH 2 group or a double bond; and

R 16 is hydrogen or together with R 15 is a —CH 2 group or a double bond,

in the presence of a base,

with a prop-1-yn-3-ol ether of formula IV

wherein

R 40 , R 41 , R 42 are, independently of one another, hydrogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy.

11. A process according to claim 10 , wherein the prop-1-yn-3-ol ether is a compound of formula IVa

Assignments (2)
CHANGE OF NAME Recorded Jul 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030719/0474 →
CHANGE OF NAME Recorded Nov 11, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029277/0286 →